THOMAS MORGAN: Open Payments
NPI 1073600755 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 10 payments from 3 companies in 2025. Trend: 2023 $167 · 2024 $243 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Ozempic, Wegovy, CAPLYTA.
Industry payments across NE — which companies pay providers there.
